US court turns down Russia tycoon Deripaska’s libel suit against APWorld October 18, 4:13
Moscow court prolongs house arrest for director Serebrennikov to Jan 19, 2018World October 18, 1:11
Rusisan tennis star Sharapova comments on her performance in VTB Kremlin CupSport October 17, 19:29
Russia blacklists almost 400 football fansSport October 17, 18:48
Window for dialogue with Ukraine still open — diplomatRussian Politics & Diplomacy October 17, 18:40
Sharapova out of 2017 VTB Kremlin Cup in Moscow after 1st roundSport October 17, 18:35
Ten Russian universities included in Times Higher Education rankingSociety & Culture October 17, 18:00
Diplomat reveals foreign structures behind wave of fake ‘Russian embassy’ accountsRussian Politics & Diplomacy October 17, 16:57
Russian Guard, police may get electroshock shields for special operationsMilitary & Defense October 17, 16:41
MOSCOW, June 19. /ITAR-TASS/. Russian pharmaceutical producer R-Pharm will invest €30 million in constructing a biotechnological plant in Turkey, CEO Vasily Ignatyev said late on Wednesday.
In 2013, R-Pharm established a joint venture with a Turkish partner aimed at selling R-Pharm’s medicines in Turkey, the Middle East and the northern Africa.
“We hope to get all necessary documents for clearance until the end of the year and to start the earthworks. We plan to finish the construction and to set up equipment until the end of 2016. The commercial launch will be made, as we expect, in late 2017,” Ignatyev said.
R-Pharm will invest €100 million in its Turkish business until 2018, he said.
Ignatyev separately said that the company will close the deal to purchase a plant from a large pharmaceutical company in Germany until the end of 2014.